Repligen

RGEN · NASDAQ

$178.88+$2.45 (+1.39%)TodayMarket closed ·
Prev close $176.43

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Employees
2,000
Headquarters
Waltham, Massachusetts
Listed
Apr 29, 1986
Sector
Health Care
Industry
Life Sciences Tools & Services

Leadership

Repligen executives
NameTitleSince
Tony Hunt—2014
Olivier Loeillot—2023
Jason Garland——
James Bylund——
Ralf Kuriyel——
Karen Dawes—2005
Nicolas Barthelemy——
Konstantin Konstantinov——
Martin Madaus——
Carrie Manner——
Rohin Mhatre——
Glenn Muir——
Margaret Pax——

Revenue by product and region

Fiscal year ended Dec 31, 2019: $270.25M total revenue

By product

  • Product [Member]$270.10M99.9%
  • Product [Member]$270.10M99.9%
  • Product [Member]$270.10M99.9%
  • Filtration Products [Member]$119.53M44.2%
  • Proteins Products [Member]$65.12M24.1%
  • Other$85.73M31.7%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Repligen suppliers and customers
CompanyRelationshipCorrelation
Danaher DHRCustomer0.82
Ecolab ECLCustomer0.77
Merck MRK.DECustomer0.63
Gemini Therapeutics GMTXSupplier and customer0.07
Pfizer PFECustomer-0.08
Navigo Proteins GmbHSupplier and customer—

Similar companies

Companies in the same industry as Repligen

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.